• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Which VCs are set to make a killing in GitLab’s IPO

September 20, 2021 by David Barret Leave a Comment

Picking up where we left off Friday, let’s spend some more time in the GitLab IPO filing.

It’s going to be an IPO week, mind; Toast and Freshworks are set to price Tuesday after the close of trading and begin to float on Wednesday. Expect final notes on the value of each and reports on how they trade when they do. The Exchange will also try to get on calls with the CEOs. But because it is Disrupt week, things are going to be a little chaotic.


The Exchange explores startups, markets and money.

Read it every morning on Extra Crunch or get The Exchange newsletter every Saturday.


But that’s tomorrow. This morning, we’re digging back into developer toolkit GitLab and its impending IPO. Let’s start with a dive into the venture capital players that are going to make out in its public offering. And for the sake of having fun on a Monday, we’ll look back at the GitHub-Microsoft deal. The former CTO of GitHub dropped some interesting data on the company’s historical results that we can use to back into what the deal would be worth today if it happened.

From there, we have some extrapolation to do. And we’ll close with an examination of GitLab’s quarterly data to see if a more narrow view of the company’s operating results tells us anything useful. Let’s have some fun!

GitLab’s rich list

As a private company, GitLab raised huge sums of capital — more than $400 million, per Crunchbase data. The capital came in increasingly large chunks from the company’s seed rounds back in 2015 through its late 2019 Series E.

Khosla Ventures led the company’s early rounds before GV, Goldman Sachs and ICONIQ Capital took the baton.

Unsurprisingly, those names are the ones we can spy on in the company’s major shareholder list. From the GitLab S-1 filing, what follows are share counts and percentage ownership stakes for the company’s investors that own more than 5% of its stock:

  • August Capital: 14,931,200 Class B shares, or 11.1% of that equity class
  • GV: 8,888,776 Class B shares, or 6.6% of that equity class
  • ICONIQ: 15,472,204 Class B shares, or 11.6% of that equity class
  • ICONIQ: 1,150,784 Class A shares, or 100% of that equity class (to be diluted in IPO)
  • Khosla: 19,028,320 Class B shares, or 14.1% of that equity class

Given that GitLab was valued at $6 billion earlier this year in a secondary transaction, the percentages above convert to huge sums. August Capital, for example, at that price point, is set to reap north of $600 million. That’s bigger than the entire fund from which it snagged ownership, the firm’s $450 million Fund VII.

Source Link Which VCs are set to make a killing in GitLab’s IPO

David Barret
David Barret

Related posts:

  1. Tennis-Sabalenka defeats Mertens in straight sets in U.S. Open fourth round
  2. China’s export, import growth likely eased in Aug on COVID-19 cases, supply bottlenecks: Reuters poll
  3. Apple and Google bow to pressure in Russia to remove Kremlin critic’s tactical voting app
  4. Iran joins expanding Asian security body led by Moscow, Beijing

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • RFK Jr’s New Vaccine Advisors Just Recommended Fall Flu Vaccines – But There’s A Catch
  • Controversial World-First Project To Create Human DNA From Scratch Takes First Steps
  • Humans Weren’t The First Species To Travel Around The Moon. They Lost This Race To An Unexpected Animal
  • When You Hack A Shark, You’re Exploiting A Glitch Billions Of Years In The Making
  • Wellness Whales, A New Blood Type, And A DJ Set From Space
  • Hate Flying Ants? We Used To Have Ones The Size Of Hummingbirds
  • ‘Tis The Season To See Titan Cast A Shadow On Saturn – Especially If You Are In America
  • World’s Bravest Vets Put Full Metal Dental Crown On A Bear For The First Time
  • “Spider Rain”: The Bizarre Phenomenon That’ll Send Arachnophobes Into A Spin
  • Scientists Gave Mice A Human “Language Gene” And Something Curious Unfolded
  • Surveillance Of People Is More “Pervasive And Normalised” Than Previously Thought, Endangering Our Privacy
  • US Sees 90 Percent Drop In Heart Attack Deaths Over Last 50 Years
  • Is A Cat Poop Parasite Decapitating Human Sperm Contributing To Rising Infertility?
  • How Fast Were Dinosaurs? Guineafowl Races Reveal They Were Probably Slower Than We Thought
  • New Claim For World’s Oldest Rocks Dates Back A Whopping 4.16 Billion Years
  • Pre-Inca Temple Was A “Ritual Gateway” To Lost Civilization Of Tiwanaku
  • NASA Study Gave Illegal Drugs To Spiders And Watched What Happened To Their Webs
  • Space Selfies & DJing A Party From Orbit – How Astronaut Luca Parmitano Brought Space To Earth
  • Regardless Of Political Affiliation, Most US Adults Actually Support Vaccine Requirements For Kids
  • Now Is The Perfect Time To See The “Summer Triangle”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version